Literature DB >> 2847037

Modification of DNA by mitomycin C in cancer patients detected by 32P-postlabeling analysis.

S Kato1, K Yamashita, T Kim, T Tajiri, M Onda, S Sato.   

Abstract

DNA adducts of mitomycin C (MMC) were detected by 32P-postlabeling analysis in both surgical specimens and an autopsy sample of the liver of patients with hepatocellular carcinoma who had received chemotherapy with MMC. Four kinds of adducts were detected in all 6 patients treated with MMC. These adducts had identical chromatographic mobilities to those of adducts in the liver of rats treated with MMC, but 1 additional adduct was detected in rat liver. In patients treated with MMC, about 3 adducts/10(8) nucleotides were found 4 days after MMC treatment, and 1 adduct/10(8) nucleotides 14 days after treatment and the latter level was maintained for up to 56 days. MMC-DNA adducts were also detected in peripheral blood leukocytes from a patient 1 and 7 days after MMC treatment, at levels of 1 and 0.6 adduct/10(8) nucleotides, respectively. These results suggest the tumor-initiating activity of MMC in humans.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2847037     DOI: 10.1016/0027-5107(88)90167-4

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  3 in total

Review 1.  DNA adducts as exposure biomarkers and indicators of cancer risk.

Authors:  M C Poirier
Journal:  Environ Health Perspect       Date:  1997-06       Impact factor: 9.031

Review 2.  Human DNA adduct measurements: state of the art.

Authors:  M C Poirier; A Weston
Journal:  Environ Health Perspect       Date:  1996-10       Impact factor: 9.031

3.  Platinum drug-DNA interactions in human tissues measured by cisplatin-DNA enzyme-linked immunosorbent assay and atomic absorbance spectroscopy.

Authors:  M C Poirier; E Reed; H Shamkhani; R E Tarone; S Gupta-Burt
Journal:  Environ Health Perspect       Date:  1993-03       Impact factor: 9.031

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.